884500-82-7

Basic information

• Product Name: 4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)-
• Synonyms: 4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)-;2-(4-methoxyphenyl)-4H-pyrano[2,3-b]pyridin-4-one;2-(4-Methoxyphenyl)pyrano[2,3-b]pyridin-4-one
• CAS NO: 884500-82-7
• Molecular Formula: C15H11NO3
• Molecular Weight: 253.25
• Mol File: 884500-82-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 425.278°C at 760 mmHg
• Flash Point: 211.001°C
• Appearance: /
• Density: 1.289g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.619
• CAS DataBase Reference: 4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)-(884500-82-7)
• EPA Substance Registry System: 4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)-(884500-82-7)

Safety Data

• Hazardous Substances Data: 884500-82-7(Hazardous Substances Data)

Usage

General Description

4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)- is a chemical compound with a molecular formula C17H13NO3. It is a pyrano-pyridin-4-one derivative that contains a 4-methoxyphenyl group. 4H-Pyrano[2,3-b]pyridin-4-one, 2-(4-methoxyphenyl)- has potential pharmaceutical applications due to its ability to act as a bioactive agent. It may have properties that are useful in the development of new drugs or therapeutics. Additionally, its unique structural features make it of interest to researchers and chemists for further investigation and potential uses in various fields of science and medicine.

InChI:InChI=1/C15H11NO3/c1-18-11-6-4-10(5-7-11)14-9-13(17)12-3-2-8-16-15(12)19-14/h2-9H,1H3

Upstream product

• 67367-26-4 2-methoxynicotinic acid methyl ester 
• 1452-94-4 ethyl 2-chloronicotinate 
• 1301225-28-4 C₁₅H₁₂ClNO₃ 
• 40134-18-7 methyl 2-chloropyridine-3-carboxylate 
• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 884501-75-1 1-(4-methoxyphenyl)-3-(2-methoxypyridin-3-yl)propane-1,3-dione 

Relevant articles and documents

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer as well as sepsis

PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF COMPLEX DISEASES AND THEIR DELIVERY BY INSERTABLE MEDICAL DEVICES

The present invention relates to polyphenol-like compounds that are useful for inhibiting VCAM-1 expression, MCP-1 expression and/or SMC proliferation in a mammal. The disclosed compounds are useful for regulating markers of inflammatory conditions, including vascular inflammation, and for treatment and prevention of inflammatory and cardiovascular diseases and related disease states.